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Materials and Methods.  All reactions involving metal complexes were conducted in 
oven-dried glassware under a nitrogen atmosphere using standard glovebox techniques.  
Solvents were prepared by passage through alumina.  All commercially obtained reagents 
were used as received.  Organic reagents were purchased from Sigma-Aldrich and metal 
salts obtained from Strem.  NiClPh(PPh3)21 and NiBrMes(PPh3)22 were prepared 
according to literature procedures.  The synthesis of compound 1 is described elsewhere.3  
1H, 13C and 31P NMR spectra were recorded on a Varian Mercury 300 spectrometer (at 
300 MHz, 75 MHz and 121 MHz respectively) or a Varian Inova 500 spectrometer (at 
500 MHz, 125 MHz and 203 MHz respectively) and are reported relative to Me4Si (δ 0.0) 
for 1H and 13C, and H3PO4 (δ 0.0) for 31P.  Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and integration.  
Data for 13C and 31P NMR spectra are reported in terms of chemical shift. 
 
N-(2,6-Diisopropylphenyl)-N-benzylidene-N´-(2-hydroxy-3-(adamant-1-yl)-5-
methylphenyl)-ethylene diimine triphenylphosphine nickel(II) (2).  1-(2,6-
Diisopropylphenyl)-3-(2-hydroxy-3-(adamant-1-yl)-5-methylphenyl)-4,5-dihydro-
imidazolium chloride (1) (162 mg, 0.320 mmol, 1.00 equiv) and potassium 
hexamethyldisilazide (134 mg, 0.670 mmol, 2.10 equiv) were weighed together in a vial 
in the glovebox.  THF (~10 mL) was added to the mixture of solids, providing a light 
yellow solution with a light precipitate.  This was added to a round-bottomed flask and 
allowed to stir for ten minutes.  At this point, a solution of NiClPh(PPh3)2 (223 mg, 0.320 
mmol, 1.00 equiv) in THF (5 mL) was added, giving a dark green solution with 
precipitate.  This solution was allowed to stir at room temperature for 1 hr and then was 
filtered through Celite.  The solvent was removed under reduced pressure until ca. 2 mL 
remained.  Pentane (~15 mL) was added and the solution was allowed to sit at -40 °C 
overnight, yielding a dark green solid (163 mg, 0.190 mmol, 59% yield).  Crystals 
suitable for X-ray crystallography were grown by layering pentane over a concentrated 
solution of 2 in THF and storing this layered solution at –40 °C for two days.  The 1H 
NMR spectrum of 2 showed some broad peaks attributed to a fluxional process on the 
NMR timescale.  This is most likely due to restricted rotation of the diisopropylphenyl 
and phenyl moieties, which are adjacent in the X-ray crystallographic structure.  The 13C 
NMR spectrum of 2 features many fewer resonances than expected.  This may be due to 
the fact that several resonances may overlap, e.g. from the triphenylphosphine and 
adamantyl moieties.  In addition, the fluxional processes described above may weaken 
some signals.  1H NMR (500 MHz, CD2Cl2): δ 7.56 (t, J = 9 Hz, 6 H), 7.32 (td, J = 1.5 
Hz, 7.5 Hz, 2H), 7.23 (td, J = 1.5 Hz, 7.5 Hz, 6H), 7.16 (t, J = 7.5 Hz, 1H), 6.78 (t, J = 7 
Hz, 1H), 6.4 (d, J = 1 Hz, 1H), 6.24 (d, J = 1 Hz, 1H), 4.76 (bs, 1H), 4.16 (bs, 1H), 3.38 
(bs, 1H), 2.92 (bs, 2H), 2.26 (s, 3H), 1.92 (bs, 6H), 1.60 (bs, 3H), 1.38 (d, J = 11 Hz, 3H), 
1.24 (bs, 12 H), 1.19 (d, J = 11.5 Hz, 3H); 13C NMR (125 MHz, CD2Cl2): δ 143.5, 135.1, 
135.0, 134.9, 133.6, 133.3, 130.1, 130.0, 129.2, 128.5, 128.4, 128.2, 123.1, 113.4, 107.6, 
68.0, 45.2, 41.3, 37.7, 36.6, 30.0, 21.8; 31P NMR (121 MHz, C6D6): δ 22.6; HRMS: 
Calcd for C56H61N2ONi (M+): 866.3875. Found 866.3835. 
 
1-(2,6-Diisopropylphenyl)-3-(2-hydroxy-3-(adamant-1-yl)-5-methylphenyl)-4,5-
dihydro-imidazolyl mesityl triphenylphosphine nickel(II) (3).  This complex was 
synthesized in a manner similar to that for 3, using NiBrMes(PPh3)2 as the nickel source 
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(62% yield).  Crystals suitable for X-ray crystallography were grown by layering pentane 
over a concentrated solution of 3 in THF and storing this layered solution at –40 °C for 
two days.  The 1H NMR spectrum of 3 showed some broad peaks attributed to a fluxional 
process on the NMR timescale.  This is most likely due to restricted rotation of the 
diisopropylphenyl and mesityl moieties, which are adjacent in the X-ray crystallographic 
structure.  Upon warming a C6D6 solution of 3 to 70 °C in the NMR spectrometer, the 
broad peaks began to coalesce.  However, they did not become well-defined.  It should be 
noted that at this elevated temperature, no further reaction, i.e. mesityl-group migration, 
followed by ring-expansion, was observed. 1H NMR (500 MHz, C6D6): δ 8.47 (bs, 1H), 
7.93 (bs, 1H), 7.76 (dd, J = 8 Hz, 11.5 Hz, 1H), 7.41-7.38 (m, 2H), 7.20 (t, J = 8 Hz, 2H), 
7.06-6.98 (m, 6H), 6.94 (dd, J = 2 Hz, 8 Hz, 6H), 6.70 (bs, 1H), 6.47 (bs, 2H), 6.20 (bs, 
2H), 6.12 (bs, 1H), 5.68 (bs, 1H), 4.42 (bs, 1H), 3.68 (bs, 1H), 3.38 (bs, 1H), 3.21 (bs, 
1H), 2.99 (bs, 3H), 2.64 (s, 3H), 2.21 (bs, 3H), 2.06 (bs, 3H), 1.98 (s, 3H), 1.82 (bs, 6H), 
1.71 (s, 3H), 1.53 (dd, J = 11.5 Hz, 27 Hz, 6H), 1.12 (bs, 3H), 0.58 (bs, 3H); 1H NMR 
(500 MHz, C6D6): δ 195.4, 194.6, 158.2, 147.9, 144.5, 144.3, 141.1, 138.5, 136.8, 136.7, 
135.8, 134.6, 134.5, 132.8, 132.8, 131.9, 131.3, 131.3, 129.2, 129.1, 129.0, 128.8, 123.9, 
119.3, 117.8, 54.7, 54.7, 50.8, 41.2, 38.0, 37.7, 30.0, 21.9, 20.7; 31P NMR (203 MHz, 
C6D6): δ 19.6; HRMS: Calcd for C59H67N2ONi (M+): 908.4345. Found 908.4390. 
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Dihydroimidazolium salt 4: To a suspension of carboxylic acid I3 (2.29 g, 11.0 mmol, 
1.05 equiv) in CH2Cl2 (10.5 ml) at 23 ºC is added carbonyl diimidazole (1.79 g, 11.0 
mmol, 1.05 equiv) in one portion. The suspension is stirred until a clear solution is 
formed and CO2 evolution has ceased (5–10 min). To this solution aniline II4 (3.40 g, 
10.5 mmol, 1.00 equiv) in CH2Cl2 (10.5 ml) is added and the solution is stirred for 16 h at 
23 ºC.  The solids formed are filtered off, washed with HCl (2 M), NaOH (2 M), and 
water to afford the diamide III as a colorless solid in 61 % yield.  Melting Point 
(toluene): mp 258 ºC.  1H NMR (300 MHz, CDCl3) δ: 8.85 (s, 1H), 8.68 (s, 1 H), 8.36 (d, 
J = 8.0 Hz, 1 H), 7.84 (d, J = 8.0 Hz, 1 H), 7.42 (dd, J = 8.0, 8.0 Hz, 1 H), 7.32 (d, J = 7.7 
Hz, 1 H), 7.18 (d, J = 7.7 Hz, 1 H), 7.02 (dd, J = 7.7, 7.7 Hz, 1 H), 6.87 (s, 2 H).  Mass 
Spectrometry HRMS-FAB+ (m/z): Calcd for C25H26N2O2I, 513.1039. Found, 513.1035.  
To diamide III (2.60 g, 5.07 mmol, 1.00 equiv) in a pressure vessel (250 ml) is added 
BH3·THF in THF (1.0 M, 41 ml, 41 mmol, 8.0 equiv).  The pressure vessel is sealed and 
the solution is heated at 75 ºC for 20 h.  After cooling the pressure vessel is opened 
(CAUTION: gas evolution under pressure) and the colorless solution is poured onto 
methanol (100 ml). To this solution is added HCl (conc., 1.0 ml) and the solution is 
concentrated in vacuo.  The resulting solid is dissolved in methanol (100 ml) and 
concentrated in vacuo.  This procedure is repeated twice to afford a colorless solid.  This 
solid is suspended in triethylorthoformate (26 ml) and the suspension is placed in a 
preheated oil bath at 125 ºC for a total time of 25 min (after initial dissolution, a 
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suspension is formed after 5 min).  To the suspension is added diethylether (10 ml) and 
the solids are filtered off and washed with diethylether extensively to afford the title 
compound as colorless solid in 52 % yield, 2 steps. 
Melting Point (Et2O): mp 265 ºC (decomposition).  1H NMR (300 MHz, DMSO-d6) δ: 
8.89 (s, 1H), 7.91 (d, J = 7.7 Hz, 1 H), 7.62–7.55 (m, 3 H), 7.46 (d, J = 7.7 Hz, 1 H), 7.18 
(dd, J = 7.7, 7.7 Hz, 1 H), 7.02 (s, 2 H), 4.12–4.08 (m, 4 H), 2.25 (s, 3 H), 2.19 (s, 3 H), 
2.02 (s, 3 H), 2.03 (s, 3 H), 1.95 (s, 3 H).  13C NMR (75 MHz, DMSO-d6) δ: 158.6, 
139.9, 139.6, 138.5, 138.1, 137.8, 137.1, 135.2, 133.7, 131.5, 130.7, 130.7, 129.5, 129.3, 
124.2, 101.1, 51.4, 50.9, 21.1, 20.5, 19.2.  Mass Spectrometry HRMS-FAB+ (m/z): Calcd 
for C26H28N2I, 495.1298. Found, 495.1322. 
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To fine ground NaOH (2.26 g, 56.5 mmol, 20.0 equiv) in CDCl3 (14 ml) prestirred for 2 
min is added dihydroimidazolium salt 4 (1.50 g, 2.83 mmol, 1.00 equiv) and the 
suspension is vigorously stirred at 20 ºC for 1 h.  This suspension is poured onto 
CH2Cl2/icewater.  The aqueous phase is extracted with CH2Cl2 (2 × 20 ml).  The 
combined organic layers are washed with brine, dried over Na2SO4 and concentrated in 
vacuo to afford a colorless solid.  This residue is purified by chromatography on silica gel 
eluting with hexane/EtOAc (20:1) to afford the title compound as a 3:1 mixture of 
diastereomers as a colorless foam in 86 % yield.  The diastereomers were not separated 
due to the instability of the product, instead the product was used immediately in the 
subsequent step.  Integrals for the 1H NMR spectrum are not given, because of the 
product mixture.  1H NMR (300 MHz, CDCl3) δ: 7.82 (d, J = 7.7 Hz), 7.76 (d, J = 7.7 
Hz), 7.36–7.28 (m), 6.99–6.76 (m), 3.62–3.51 (m), 3.05–2.93 (m), 2.48, 2.45, 2.35, 2.32, 
2.29, 2.25, 2.24, 2.20, 1.91, 1.83.  Mass Spectrometry HRMS-FAB+ (m/z): Calcd for 
C27H28N22HCl3I, 614.0505. Found, 614.0524. 
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Phosphonium salt 7:  To the mixture of chloroform adducts 5 (725 mg, 1.18 mmol, 1.00 
equiv) at –78 ºC is added THF (6.0 ml) (5 decomposes if dissolved in THF at room 
temperature).  The solution is cooled to –100 ºC and tert-butyllithium in pentane (1.60 M, 
1.55 ml, 2.48 mmol, 2.10 equiv) is added. After 5 min at –100 ºC, 
chlorodiphenylphosphine (313 mg, 1.42 mmol, 1.20 equiv, 254 µl) is added and the 
solution is warmed to –40 ºC and stirred at this temperature for 2.5 h.  To this solution at 
–40 ºC is added HCl in diethylether(1.0 M, 2.4 ml, 2.4 mmol, 2.0 equiv) followed by 
methanol (300 µl).  The solution is poured onto CH2Cl2/HCl (1 M). The aqueous phase is 
extracted with CH2Cl2 (3 × 20 ml).  The combined organic layers are washed with brine, 
dried over Na2SO4 and concentrated in vacuo to afford a yellow solid.  This residue is 
purified by chromatography on silica gel eluting with CH2Cl2/MeOH (9:1) to afford the 
title compound as pale yellow crystals in 51 % yield. 
Melting Point (CH2Cl2/pentane): mp 275 ºC (decomposition).  1H NMR (300 MHz, 
CD2Cl2) δ: 7.85–7.82 (m, 1 H), 7.77–7.74 (m, 1 H), 7.70–7.42 (m, 8 H), 7.36–7.19 (m, 5 
H), 6.90–6.89 (m, 2 H), 6.73–6.71 (m, 1 H), 5.99 (d, J = 8.5 Hz, 1 H), 4.17–4.09 (m, 1 
H), 4.02–3.93 (m, 1 H), 3.64–3.53 (m, 2 H), 2.25 (s, 3 H), 2.24 (s, 3 H), 2.16 (s, 3 H), 
2.14 (s, 3 H), 2.58 (s, 3 H).  13C NMR (74 MHz, CD2Cl2, coupling constants to 31P given 
for established doublets only, other signals are reported as peaks) δ: 143.5, 143.3, 140.5, 
139.5, 139.4, 139.1, 138.2, 136.3, 136.2, 136.0, 135.8, 138.8, 135.7, 134.9, 134.9, 134.9, 
134.5, 133.9, 133.9, 132.2, 132.2, 131.4, 131.2, 130.5, 130.3, 130.1, 129.6, 129.5, 129.5, 
129.4, 129.3, 128.5, 128.4, 128.0, 121.3, 120.2, 120.1, 119.0, 117.4, 116.9, 115.8, 99.4 
(d, J = 136.0 Hz), 48.6 (d, J = 7.7 Hz), 47.4, 20.6, 19.4, 19.3, 18.2, 18.0.  31P NMR (121 
MHz, CD2Cl2) δ: 19.1.  Mass Spectrometry HRMS-FAB+ (m/z): Calcd for C39H38N2P, 
565.2773. Found, 565.2746.  Crystallographic data have been deposited at the CCDC, 12 
Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on request, free of 
charge, by quoting the publication citation and the deposition number 267284. 
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When using 13C labeled chloroform, in the preparation of 7l, the 13C label in 7l is found 
in ring positions 2 and 3 as a 1:2 ratio.  1H NMR (300 MHz, CD2Cl2) δ: 5.99 (dd, 1JHC = 
174.9 Hz, 3JHP = 8.5 Hz), 5.99 (dd, 2JHC = 8.5 Hz, 3JHP = 8.5 Hz).  13C NMR (74 MHz, 
CD2Cl2) δ: 134.7 (d, 2JCP = 28.5 Hz), 99.4 (d, 1JCP = 136.0 Hz).  Mass Spectrometry 
HRMS-FAB+ (m/z): Calcd for C38H38N213CP, 566.2806. Found, 566.2800. 
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Phosphonium salt IV:  The phosphonium salt IV has been prepared analogously to 7.  
Melting Point (CH2Cl2/pentane): mp 306 ºC (decomposition).  1H NMR (300 MHz, 
CD2Cl2) δ: 7.79 (dd, J = 8.9, 8.3 Hz, 1 H), 7.69 (d, J = 7.7 Hz, 1 H), 7.60 (ddd, J = 7.7, 
7.7., 3.3 Hz, 1 H), 7.45 (dd, J = 8.0, 7.7 Hz, 1 H), 7.31 (d, J = 7.7 Hz, 1 H), 7.24 (d, J = 
7.4 Hz, 1 H), 6.97 (s, 2 H), 6.40 (d, J = 6.31 Hz, 1 H), 3.99–3.89 (m, 2 H), 3.51–3.35 (m, 
2 H), 2.91 (q, J = 12.4 Hz, 1 H), 2.36–0.84 (m, 21 H), 2.30 (s, 3 H), 2.21 (s, 3 H), 2.15 (s, 
3 H), 2.11 (s, 3 H), 2.02 (s, 3 H).  13C NMR (74 MHz, CD2Cl2, coupling constants to 31P 
given for established doublets only, other signals are reported as peaks) δ: 148.9, 143.9, 
143.8, 140.4, 139.9, 139.8, 139.3, 138.4, 136.7, 135.8, 135.7, 134.9, 132.6, 130.7, 129.7, 
129.7, 129.5, 129.5, 128.4, 128.2, 117.1, 116.2, 115.2, 96.2 (d, J = 116.4 Hz), 47.5 (d, J = 
6.9 Hz), 36.2 (d, J = 49.2 Hz), 31.9 (d, J = 41.5 Hz), 27.3, 27.3, 27.1, 26.7, 26.5, 26.5, 
26.4, 26.3, 26.0, 25.5, 25.2, 20.7, 19.9, 19.4, 17.8, 17.7.  31P NMR (121 MHz, CD2Cl2) δ: 
27.7.  Mass Spectrometry HRMS-FAB+ (m/z): Calcd for C39H50N2P, 577.3712. Found, 
577.3727. 
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